The GeneTitan Multi-Channel Instrument from Thermo Fisher Scientific offers streamlining array processing for discovery, exploration, and screening. The GeneTitan Instrument for expression applications and the […]
Orfadin, an oral suspension which is meant to treat hereditary tyrosinemia type 1 (HT-1), has been approved by Health Canada.
A recent forecast expects the global insomnia therapeutics market to reach US$3.45 billion by 2025.
Encycle Therapeutics is working with Pfizer Inc. to further the Toronto-based start-up drug discovery company’s research in synthetic nacellins.